BIYKEM BOZKURT to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications BIYKEM BOZKURT has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.315
-
Joint HFSA/ACC/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19. J Card Fail. 2020 05; 26(5):370.
Score: 0.619
-
What to and Not to Monitor for Uptitration of GDMT in Patients With Heart?Failure: The Case for Patient Self-Uptitration of GDMT. JACC Heart Fail. 2022 11; 10(11):881-884.
Score: 0.184
-
Heart?Failure Drug Treatment-Inertia,?Titration, and Discontinuation: A Multinational Observational Study (EVOLUTION HF). JACC Heart Fail. 2023 01; 11(1):1-14.
Score: 0.182
-
WORSENING RENAL FUNCTION IN ACUTE DECOMPENSATED HEART FAILURE: A BAD SIGN, OR MAYBE NOT? Trans Am Clin Climatol Assoc. 2019; 130:41-50.
Score: 0.141
-
Impact of alpha 1-adrenergic antagonist use for benign prostatic hypertrophy on outcomes in patients with heart failure. Am J Cardiol. 2009 Jul 15; 104(2):270-5.
Score: 0.073
-
Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy. Am J Cardiol. 2008 Nov 15; 102(10):1356-60.
Score: 0.069
-
Medical and surgical therapy for cardiac remodeling. Curr Opin Cardiol. 1999 May; 14(3):196-205.
Score: 0.036
-
Experimental options in the treatment of heart failure: the role of cytokine antagonism. Heart Fail Monit. 2001; 1(4):114-21.
Score: 0.010